Literature DB >> 31750026

Respiratory complications and 30-day unplanned hospital readmissions in patients with epilepsy.

Radhika Parikh1, Romil Parikh1, Smit Patel1, Ninad Desai1, Tapan Mehta1, Renee Stapleton1.   

Abstract

BACKGROUND: To help mitigate the burden of health care on US economy, public policymakers and health care legislation have been focusing on reducing hospital readmissions. Respiratory complications have been identified among the commonest of adverse events in neurologic patients. The goal of our study was to better understand respiratory complications and their contribution to rehospitalizations in patients with seizures.
METHODS: We used the 2013 Nationwide Readmission Database to analyze unplanned 30-day readmission rate (30RR). The study population comprised of patients with index hospital discharge diagnosis of generalized convulsive epilepsy and status epilepticus. Patients under 18 years of age, who died during hospitalization or who had missing demographic data, were excluded. Patients hospitalized in December were also excluded due to lack of 30-day follow-up. The primary outcome of interest was 30-day readmission. The causes of readmission were determined by corresponding International Classification of Diseases, Ninth Revision, Clinical Modification codes.
RESULTS: The 30RR was highest in patients with index hospitalization discharge diagnosis of status epilepticus, followed by generalized convulsive epilepsy (intractable), followed by generalized convulsive epilepsy (nonintractable). While seizure was the most common reason for readmission, contribution of respiratory complications to readmissions was 7.85%, 12.39%, and 6.93%, respectively. Pneumonia/aspiration pneumonitis and respiratory insufficiency accounted for the majority of the readmissions in all subgroups.
CONCLUSIONS: Respiratory complications are the leading nonseizure cause of 30-day unplanned readmissions in patients with generalized convulsive epilepsy and status epilepticus. Further research on identifying appropriate interventions to reduce readmissions from respiratory causes may improve outcomes for patients in these epilepsy subgroups.
© 2019 American Academy of Neurology.

Entities:  

Year:  2019        PMID: 31750026      PMCID: PMC6814417          DOI: 10.1212/CPJ.0000000000000672

Source DB:  PubMed          Journal:  Neurol Clin Pract        ISSN: 2163-0402


  19 in total

1.  Performance of comorbidity scores to control for confounding in epidemiologic studies using claims data.

Authors:  S Schneeweiss; J D Seeger; M Maclure; P S Wang; J Avorn; R J Glynn
Journal:  Am J Epidemiol       Date:  2001-11-01       Impact factor: 4.897

2.  Adapting a clinical comorbidity index for use with ICD-9-CM administrative databases.

Authors:  R A Deyo; D C Cherkin; M A Ciol
Journal:  J Clin Epidemiol       Date:  1992-06       Impact factor: 6.437

3.  The Use of Benzodiazepine Receptor Agonists and Risk of Respiratory Failure in Patients with Chronic Obstructive Pulmonary Disease: A Nationwide Population-Based Case-Control Study.

Authors:  Su-Jung Chen; Chiu-Mei Yeh; Tze-Fan Chao; Chia-Jen Liu; Kang-Ling Wang; Tzeng-Ji Chen; Pesus Chou; Fu-Der Wang
Journal:  Sleep       Date:  2015-07-01       Impact factor: 5.849

4.  Ventilator settings and outcome of respiratory failure in chronic interstitial lung disease.

Authors:  Evans R Fernández-Pérez; Murat Yilmaz; Hussam Jenad; Craig E Daniels; Jay H Ryu; Rolf D Hubmayr; Ognjen Gajic
Journal:  Chest       Date:  2007-11-07       Impact factor: 9.410

5.  Regional disparities in the quality of stroke care.

Authors:  Seth Seabury; Katalin Bognar; Yaping Xu; Caroline Huber; S Renee Commerford; Darren Tayama
Journal:  Am J Emerg Med       Date:  2017-03-19       Impact factor: 2.469

Review 6.  The direct cost of epilepsy in the United States: A systematic review of estimates.

Authors:  Charles E Begley; Tracy L Durgin
Journal:  Epilepsia       Date:  2015-07-27       Impact factor: 5.864

7.  Mortality from epilepsy: results from a prospective population-based study.

Authors:  O C Cockerell; A L Johnson; J W Sander; Y M Hart; D M Goodridge; S D Shorvon
Journal:  Lancet       Date:  1994-10-01       Impact factor: 79.321

8.  Association of chronic mucus hypersecretion with FEV1 decline and chronic obstructive pulmonary disease morbidity. Copenhagen City Heart Study Group.

Authors:  J Vestbo; E Prescott; P Lange
Journal:  Am J Respir Crit Care Med       Date:  1996-05       Impact factor: 21.405

9.  Nasal airflow monitoring during swallowing: Evidences for respiratory-swallowing incoordination in individuals with chronic obstructive pulmonary disease.

Authors:  Calida Frieda Pinto; Radish Kumar Balasubramanium; Vishak Acharya
Journal:  Lung India       Date:  2017 May-Jun

10.  National and State Estimates of the Numbers of Adults and Children with Active Epilepsy - United States, 2015.

Authors:  Matthew M Zack; Rosemarie Kobau
Journal:  MMWR Morb Mortal Wkly Rep       Date:  2017-08-11       Impact factor: 17.586

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.